Digital Molecules, DTx, and a breakthrough in chronic cough Early evidence for a cough treatment digital therapeutic is compelling.
News Kyorin partners Hyfe to develop DTx for chronic cough Kyorin Pharma has signed a deal with Hyfe to develop a digital therapeutic (DTx) for people with chronic cough and launch it in Japan.
Patients Chronic cough and the patient voice Chronic cough impacts up to 10% of the adult population and has a physical, psychological, and social impact on patients’ lives.
News FDA removes barriers to cell, gene therapy development FDA wants to exert regulatory flexibility on cell and gene therapies in an effort to bring them to patients more quickly and efficiently.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
